
Strep A Pathogen Testing with Acutis Reveal™
Acutis Reveal™ PIT is an FDA-cleared molecular test that quickly identifies the Group A β-hemolytic Streptococcus pyogenes pathogen responsible for Strep A disease.
Acutis Reveal™ Acutis Reveal™ PIT (Strep A) is an FDA-cleared molecular test that quickly identifies the Group A β-hemolytic Streptococcus pyogenes pathogen responsible for Strep A disease.
Acutis Reveal™ PIT (Strep A) is an FDA-cleared molecular test that quickly identifies the Group A β-hemolytic Streptococcus pyogenes pathogen responsible for Strep A disease.
Start testing with us today
Benefits of Acutis Reveal™ PIT at a glance
1
fast one-step treatment that requires only a simple throat swab and transport media
2
Rapid confirmation, within 24 hours from the time a sample is received
3
New degrees of certainty determine whether the illness is bacterial or viral in nature, and so whether a course of antibiotics is necessary
4
Highly accurate data confirms best treatment options and outcomes for your patients
5
Streamlined patient management, which eliminates costs, while relieving patients, particularly parents of children
The FDA-cleared molecular detection test that simplifies the clinical scenario

The FDA-approved test detects the major pharyngeal pathogen responsible for Strep A:
bacterial targets
-
Streptococcus pyogenes